$KRRO

$13.30 +$1.28 (10.65%) Close

$KRRO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$KRRO Management Team

Ms. Stephanie Engels

Senior Vice President - People and Culture

Age -

Compensation -

Sex Female

Mr. Venkat Krishnamurthy

Senior Vice President - Platform

Age -

Compensation -

Sex Male

Dr. Nessan Bermingham

Independent Chairman of the Board

Age 51

Compensation $237.5K USD

Sex Male

Mr. Todd Chappell

Chief Operating Officer

Age 51

Compensation -

Sex Male

Dr. Jeffrey Cerio

Senior Vice President

General Counsel

Corporate Secretary

Age -

Compensation $1.546M USD

Sex Male

Dr. Gaozhong Zhu

Senior Vice President of Chemistry

Manufacturing and Controls

Age -

Compensation -

Sex Male

Mr. Oliver Dolan

Principal Accounting Officer

Age 42

Compensation -

Sex Male

Dr. Loic Vincent

Chief Scientific Officer

Age -

Compensation -

Sex Male

Dr. Ram Aiyar

President

Chief Executive Office (Principal Executive Officer)

Interim Chief Financial Officer and Principal Financial Officer

Director

Age 47

Compensation $939.1K USD

Sex Male

Name / Title	Age	Compensation	Sex
Ms. Stephanie Engels Senior Vice President - People and Culture	-	-	Female
Mr. Venkat Krishnamurthy Senior Vice President - Platform	-	-	Male
Dr. Nessan Bermingham Independent Chairman of the Board	51	$237.5K USD	Male
Mr. Todd Chappell Chief Operating Officer	51	-	Male
Dr. Jeffrey Cerio Senior Vice President General Counsel Corporate Secretary	-	$1.546M USD	Male
Dr. Gaozhong Zhu Senior Vice President of Chemistry Manufacturing and Controls	-	-	Male
Mr. Oliver Dolan Principal Accounting Officer	42	-	Male
Dr. Loic Vincent Chief Scientific Officer	-	-	Male
Dr. Ram Aiyar President Chief Executive Office (Principal Executive Officer) Interim Chief Financial Officer and Principal Financial Officer Director	47	$939.1K USD	Male

Board of Directors

From the proxy statement filed Apr 16, 2026

Directors

serving now

Independent

0 of 1

stated in the proxy; 6 not stated

Average tenure

2.9 years

from year joined

CEO also chairs the board

Nessan Bermingham

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Nessan Bermingham Board chair	Not stated	2023 3 years	Not stated	audit compensation · Chair	None stated	$148,760
Rachel Meyers	Not stated	2023 3 years	Not stated	nominating and corporate governance	None stated	$105,260
Ram Aiyar CEO	Not stated	2023 3 years	Not independent	None stated	None stated	Paid as CEO
Ali Behbahani	Not stated	2023 3 years	Not stated	compensation nominating and corporate governance · Chair	Monte Rosa Therapeutics, Inc.	$114,260
Jean-François Formela	Not stated	2023 3 years	Not stated	audit nominating and corporate governance	None stated	$112,760
Katharine Knobil	Not stated	2024 2 years	Not stated	compensation	Marker Therapeutics, Inc.	$106,260
Timothy Pearson	Not stated	2023 3 years	Not stated	audit · Chair compensation	None stated	$121,260

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 16, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$KRRO Management Team

Ms. Stephanie Engels

Mr. Venkat Krishnamurthy

Dr. Nessan Bermingham

Mr. Todd Chappell

Dr. Jeffrey Cerio

Dr. Gaozhong Zhu

Mr. Oliver Dolan

Dr. Loic Vincent

Dr. Ram Aiyar

Board of Directors

Related-party transactions

No related-party transactions disclosed